Corporate Banner
Satellite Banner
Medicinal Chemistry
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Drug Discovery of the Year Opens for Nominations

Published: Monday, May 27, 2013
Last Updated: Sunday, May 26, 2013
Bookmark and Share
Judges welcome submissions from across the spectrum of pharmacology.

The British Pharmacological Society (BPS) has announced that it is now accepting nominations for its Drug Discovery of the Year award.

The award was established by BPS to demonstrate the importance of pharmacology in the development of new medicines, and to reward the achievements of the teams of scientists who discover new drugs.

Drug Discovery of the Year was presented last year to the team who developed vismodegib for the treatment of advanced basal cell carcinoma.

The announcement followed judging by the BPS Industry Committee, consisting of experts in industrial pharmacology, who reviewed nominations from across the world and a range of disease areas.

Professor Philip Routledge, BPS President, comments: “I am delighted to announce the details of Drug Discovery of the Year and to welcome submissions from across the whole spectrum of pharmacology. BPS intends to build on the number and high quality of the nominations received in 2012, all of which demonstrated the importance of pharmacology in drug discovery.”

This year, BPS Industry Committee will consider nominations for the discovery team behind a drug - whether a large or a small molecule - that best fulfils the following criteria:
• gained regulatory approval within the last three years in the EU and/or US
• preclinical to clinical translation shows the importance of pharmacology in the drug discovery/development process
• has a significant impact on an unmet medical need
• first-in-class, or is a significant improvement over other drugs in the class
• mechanism of action known

Nominations must be received by 1 October 2013. The winning team will be publicly announced during the BPS flagship meeting Pharmacology 2013, held in London 17-19 December 2013 and attended by an anticipated 1,000 pharmacologists.

The award neither promotes the administration, consumption, prescription, purchase, recommendation, sale, supply or use of the winning medicine; nor does it pre-empt any regulatory decisions.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,000+ scientific posters on ePosters
  • More than 4,500+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Turning Skin Cells into Heart, Brain Cells
In a major breakthrough, scientists at the Gladstone Institutes transformed skin cells into heart cells and brain cells using a combination of chemicals.
Experimental Drug Cancels Effect from Key Intellectual Disability Gene
A University of Wisconsin—Madison researcher who studies the most common genetic intellectual disability has used an experimental drug to reverse — in mice — damage from the mutation that causes the syndrome.
Doubling Down on Dengue
HMS researchers have discovered two ways a compound blocks dengue virus.
Reprogramming Scorpion Venom
‘Twist of nature’ neutralizes toxin.
Tailoring a Suit for Tumor-Penetrating Cancer Meds
For more than a decade, biomedical researchers have been looking for better ways to deliver cancer-killing medication directly to tumors in the body.
Resurrecting an Abandoned Drug
Previously discarded drug shows promise in helping human cells in a lab dish fight off two different viruses.
Safer, Cheaper, Greener and More Efficient System for Organic Synthesis
The new medium not only supports organic synthesis it also produces considerably higher yields of product than pure organic solvents.
Fighting Prostate Cancer
Identifying the most promising compounds which can be used as medications for prostate cancer.
Collaboration to Develop Cancer Therapeutics
Major license agreement with Merck, enabled by Blavatnik Biomedical Accelerator, aims to develop therapy for most common form of acute leukemia.
Faster UVA Molecular Analysis Technology
There are people in the world – chemical engineers, astronomers, national defense scientists investigating an explosion – who need to know just what something is made of, down to the molecular level.
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!